TRC105 for Recurrent Glioblastoma

NCT01778530 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

NIH

Sponsor class

Stopped Study was terminated due to poor accrual.

Conditions

Glioblastoma Multiforme

Interventions

DRUG: TRC105

Sponsor

National Cancer Institute (NCI)